Company Filing History:
Years Active: 2003-2009
Title: The Innovations of Steven Edward Lenicek
Introduction
Steven Edward Lenicek is a notable inventor based in Plainsboro, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target the central nervous system. With a total of 9 patents to his name, Lenicek's work has the potential to impact the treatment of various disorders.
Latest Patents
Among his latest patents, Lenicek has developed compounds such as 1-Heterocyclylalkyl-3-sulfonylindole or -indazole derivatives, which serve as 5-hydroxytryptamine-6 ligands. This invention provides a compound of formula I and its use for treating central nervous system disorders related to or affected by the 5-HT6 receptor. Another significant patent is for 1-(aminoalkyl)-3-sulfonylazaindoles, also functioning as 5-hydroxytryptamine-6 ligands, aimed at therapeutic treatments for disorders associated with the 5-HT6 receptor.
Career Highlights
Lenicek's career is marked by his role at Wyeth, where he has been instrumental in advancing research and development in the pharmaceutical sector. His innovative approach and dedication to improving health outcomes have established him as a respected figure in his field.
Collaborations
Throughout his career, Lenicek has collaborated with notable colleagues, including Ronald Charles Bernotas and Schuyler Adam Antane. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Steven Edward Lenicek's contributions to the field of pharmaceuticals through his patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new treatments that can significantly improve patient care.